Skip to content
biotechnology hero image
biotechnology hero image


Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.

Our team benefits from having several members of the group who have completed degrees in subjects including molecular biology, biochemistry and genetics. This knowledge enables us to quickly grasp technical concepts and provide nuanced and tailored advice.

We closely follow new developments and emerging trends in the biotech market. For example, we have been following the emerging regulatory pathways for biosimilars and advising clients on appropriate strategies.

News and insights

Person wearing protective clothing and holding apparatus in science lab

Blog Post: 03 April 2024

European Commission opens unprecedented abuse of dominance probe in animal medicines sector

The European Commission (EC) has opened a formal antitrust investigation into whether animal health company Zoetis has breached EU antitrust law by preventing the market launch of a competing novel…

Read more
Life Science

Blog Post: 28 March 2024

Czech Republic draws blood after English High Court finds serious irregularity in investment treaty arbitration award

The English High Court has upheld one of the Czech Republic’s challenges to an investment treaty award won by investors in a blood plasma business after finding that an UNCITRAL tribunal had failed to…

Read more
Water droplets

Blog Post: 17 July 2023

When is the composition of a product on the market prior art?

G1/23 – EPO Enlarged Board of Appeals of the EPO “available” (referral from T 0438/19) Under which circumstances can the public prior use of a product constitute prior art for novelty or inventive…

Read more
test tubes and dropper

Blog Post: 04 May 2023

Podcast: Scaling up science - how to grow your life sciences venture

How and when do life sciences entrepreneurs decide whether to raise more funds, partner with big pharma, or exit their company? What strategies and tactics do they apply? And what are the key lessons…

Read more